120 related articles for article (PubMed ID: 27931985)
1. Impact of regulatory measures on antipsychotics drug consumption in Castilla y León, Spain.
Martín Arias LH; Treceño Lobato C; Pérez García S; García Ortega P; Sáinz Gil M; Sanz Fadrique R; Carvajal García-Pando A
Public Health; 2016 Dec; 141():113-119. PubMed ID: 27931985
[TBL] [Abstract][Full Text] [Related]
2. Use of antipsychotic agents in Spain through 1985-2000.
Santamaría B; Pérez M; Montero D; Madurga M; de Abajo FJ
Eur Psychiatry; 2002 Dec; 17(8):471-6. PubMed ID: 12504264
[TBL] [Abstract][Full Text] [Related]
3. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate.
Treceño C; Martín Arias LH; Sáinz M; Salado I; García Ortega P; Velasco V; Jimeno N; Escudero A; Velasco A; Carvajal A
Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):435-41. PubMed ID: 22253017
[TBL] [Abstract][Full Text] [Related]
4. [Evolution of antipsychotic drug consumption in the autonomous community of Castile and Leon, Spain (1990-2001)].
García del Pozo J; Isusi Lomas L; Carvajal García-Pando A; Martín Rodríguez I; Sáinz Gil M; García del Pozo V; Velasco Martín A
Rev Esp Salud Publica; 2003; 77(6):725-33. PubMed ID: 14965064
[TBL] [Abstract][Full Text] [Related]
5. [Consumption and cost of antipsychotic drugs].
Pérez J; Marín N; Vallano A; Castells X; Capellà D
Actas Esp Psiquiatr; 2005; 33(2):110-6. PubMed ID: 15768318
[TBL] [Abstract][Full Text] [Related]
6. Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.
Wladysiuk M; Araszkiewicz A; Godman B; Szabert K; Barbui C; Haycox A
Appl Health Econ Health Policy; 2011 Mar; 9(2):101-10. PubMed ID: 21271749
[TBL] [Abstract][Full Text] [Related]
7. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
8. A pharmacoepidemiological study of the consumption of antiparkinson drugs in the Basque Autonomous Community (Spain) (1992-2004).
Osinaga EA; Inchaurregui LC; Ikobaltzeta IE; Alonso NB; Del Pozo JG
Parkinsonism Relat Disord; 2007 Dec; 13(8):500-4. PubMed ID: 17532251
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotics and antidepressants: an analysis of cost growth in Finland from 1999 to 2005.
Koskinen H; Martikainen JE; Maljanen T
Clin Ther; 2009 Jun; 31 Pt 1():1469-77. PubMed ID: 19698904
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of switching antipsychotic medication to long-acting injectable risperidone in patients with schizophrenia : a 12- and 24-month follow-up from the e-STAR database in Spain.
Olivares JM; Rodriguez-Martinez A; Burón JA; Alonso-Escolano D; Rodriguez-Morales A;
Appl Health Econ Health Policy; 2008; 6(1):41-53. PubMed ID: 18774869
[TBL] [Abstract][Full Text] [Related]
11. Cost-Minimisation Analysis of Paliperidone Palmitate Long-Acting Treatment versus Risperidone Long-Acting Treatment for Schizophrenia in Spain.
Quintero J; Oyagüez I; González B; Cuervo-Arango I; García I; Casado MA
Clin Drug Investig; 2016 Jun; 36(6):479-90. PubMed ID: 27000061
[TBL] [Abstract][Full Text] [Related]
12. Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy.
Andretta M; Ciuna A; Corbari L; Cipriani A; Barbui C
Soc Psychiatry Psychiatr Epidemiol; 2005 Jan; 40(1):72-7. PubMed ID: 15624078
[TBL] [Abstract][Full Text] [Related]
13. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
[TBL] [Abstract][Full Text] [Related]
14. [Paediatric prescribing of anti-asthmatics in primary care in Castilla-León. Geographical variability].
Casares Alonso I; Cano Garcinuño A; Blanco Quirós A; Pérez García I
An Pediatr (Barc); 2015 Sep; 83(3):191-200. PubMed ID: 26363566
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia.
Rosenheck RA; Leslie DL; Sindelar J; Miller EA; Lin H; Stroup TS; McEvoy J; Davis SM; Keefe RS; Swartz M; Perkins DO; Hsiao JK; Lieberman J;
Am J Psychiatry; 2006 Dec; 163(12):2080-9. PubMed ID: 17151158
[TBL] [Abstract][Full Text] [Related]
16. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
17. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
[TBL] [Abstract][Full Text] [Related]
18. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone].
Bret P; Bonnet F; Bret MC; Jaffré A
Encephale; 2002; 28(4):329-42. PubMed ID: 12232542
[TBL] [Abstract][Full Text] [Related]
19. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine.
Garcia del Pozo J; Carvajal A; Viloria JM; Velasco A; Garcia del Pozo V
Eur J Clin Pharmacol; 2008 Apr; 64(4):411-5. PubMed ID: 18157671
[TBL] [Abstract][Full Text] [Related]
20. The cost effectiveness of long-acting/extended-release antipsychotics for the treatment of schizophrenia: a systematic review of economic evaluations.
Achilla E; McCrone P
Appl Health Econ Health Policy; 2013 Apr; 11(2):95-106. PubMed ID: 23494934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
